37662-3691 : Indigo 100 [Hp_c]/1 Oral Pellet


NDC37662-3691
Labeler: Hahnemann Laboratories, Inc.
Product Type: Human OTC Drug
Drug Name: Indigo
Dosage Form: Oral Pellet
Rev. Date: 


NDC Package Codes:

  • 37662-3691-1: 200 PELLET IN 1 VIAL, GLASS (37662‑3691‑1)
  • 37662-3691-2: 500 PELLET IN 1 VIAL, GLASS (37662‑3691‑2)
  • 37662-3691-3: 3000 PELLET IN 1 BOTTLE, GLASS (37662‑3691‑3)
  • 37662-3691-4: 10000 PELLET IN 1 BOTTLE, GLASS (37662‑3691‑4)

Active Ingredients:

  • Indigo

Dosage Strength:

  • 100 [hp_C]/1

Related Products:

Based on records with the same trade name.
  • 37662-3688 Indigo 6 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3689 Indigo 12 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3690 Indigo 30 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3692 Indigo 200 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3693 Indigo 500 [Hp_c]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3694 Indigo 1 [Hp_m]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 37662-3695 Indigo 1 [Hp_q]/1 Oral Pellet by Hahnemann Laboratories, Inc.
  • 15631-0233 Indigo 3 [hp_x]/1 Oral Pellet by Rxhomeo Private Limited D.b.a. Rxhomeo, Inc

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 37662-3691 QR Code

< Prev: 37662-3690Next: 37662-3692 >

Related Discussions:

Beige (off white) & Purple (indigo) Capsule
Trying to figure out what this pill is from a photo. Doesn't seem to have any markings on it but might be on the oth... 3 replies
indigo carmine
need to know UAD, and involvement in surgery ## Indigo Carmine Info Click Here --Chemical... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.